D3/2Gαi1 | D3/2Gαi2 | D3/2Gαi3 | D3/2Gαo1 | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
pEC50 (±S.E.M.) | Emax | pEC50 (±S.E.M.) | Emax | pEC50 (±S.E.M.) | Emax | pEC50 | Emax | |||||
%DA (±S.E.M.) | %DA (±S.E.M.) | %DA (±S.E.M.) | %DA (±S.E.M.) | |||||||||
Dopamine | 5.3 (0.06) | 100 | 5.6 (0.18) | 100 | 7.2 (0.32) | 100 | 7.3 (0.12) | 100 | ||||
m-Tyramine | N.A. | 4.1 (0.16) | 53 (9) | 6.2 (0.17) | 81 (9) | 6.4 (0.09) | 79 (3) | |||||
p-Tyramine | N.A. | N.A. | 5.5 (0.14) | 45 (5) | 5.2 (0.16) | 80 (1) | ||||||
R-(+)-3-PPP | N.A. | 4.1 (0.24) | 68 (11) | 6.1 (0.08) | 68 (7) | 6.0 (0.14) | 92 (4) | |||||
S-(-)-3-PPP | N.A. | N.A. | 6.7 (0.36) | 40 (3) | 6.9 (0.10) | 50 (4) | ||||||
Quinpirole | 5.6 (0.09) | 120 (13) | 5.3 (0.69) | 120 (3) | 7.4 (0.21) | 100 (4) | 7.6 (0.08) | 100 (3) | ||||
NPA | 9.4 (0.08) | 120 (12) | 8.6 (0.06) | 120 (1) | 9.3 (0.03) | 91 (3) | 9.1 (0.02) | 110 (2) | ||||
7-OH-DPAT | 10 (0.19) | 76 (8) | N.A. |
| 11 (0.88) | 34 (5) | 10 (0.03) | 64 (1) |
N.A., no detectable stimulation.